1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and molecular predictors of response to immune checkpoint inhibitors in patients with advanced esophagogastric cancer
    Journal Article

    Greally, M.; Chou, J. F.; Chatila, W. K.; Margolis, M.; Capanu, M.; Hechtman, J. F.; Tuvy, Y.; Kundra, R.; Daian, F.; Ladanyi, M.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Immunopathologic stratification of colorectal cancer for checkpoint blockade immunotherapy
    Journal Article

    Llosa, N. J.; Luber, B.; Siegel, N.; Awan, A. H.; Oke, T.; Zhu, Q.; Bartlett, B. R.; Aulakh, L. K.; Thompson, E. D.; Jaffee, E. M.; more...
    Cancer Immunology Research (2019)

    Fulltext@MSK | Save
  • Ablative RT results in excellent local control and survival in localized pancreatic cancer
    Meeting Abstract

    Reyngold, M.; O'Reilly, E.; Zinovoy, M.; Romesser, P. B.; Wu, A. J.; Hajj, C.; Cuaron, J. J.; Yorke, E. D.; Varghese, A. M.; Crane, C. H.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Post-treatment ANC is predictive of poorer overall survival and disease-free survival in esophageal cancer patients after tri-modality therapy
    Meeting Abstract

    Zhang, M.; Jackson, A.; Montovano, M.; Ku, G.; Janjigian, Y.; Ilson, D. H.; Yorke, E. D.; Crane, C. H.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Genetic determinants of chemoradiation response and survival in locally advanced esophageal carcinoma treated with trimodality therapy
    Meeting Abstract

    Pitter, K. L.; Casey, D. L.; Oh, P.; Setton, J.; Ku, G.; Ilson, D. H.; Janjigian, Y.; Bains, M. S.; Jones, D.; Molena, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Quality-adjusted life-years accrued with cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial
    Meeting Abstract

    Strasser, S.; Abou-Alfa, G.; Mollon, P.; Meyer, T.; Cheng, A.; El-Khoueiry, A.; Kelley, R.; Baron, A.; Benzaghou, F.; Valcheva, V.; more...
    Journal of Gastroenterology and Hepatology (2019)

    Fulltext@MSK | Save
  • Outcomes based on plasma biomarkers for the phase III CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma
    Meeting Abstract

    Zekry, A.; Rimassa, L.; Kelley, R.; Meyer, T.; Ryoo, B.; Merle, P.; Park, J.; Blanc, J.; Lim, H.; Tran, A.; more...
    Journal of Gastroenterology and Hepatology (2019)

    Fulltext@MSK | Save
  • Association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma in the phase III CELESTIAL trial
    Meeting Abstract

    Strasser, S.; Abou-Alfa, G.; Meyer, T.; Cheng, A.; Cicin, I.; Bolondi, L.; Klumpen, H.; Chan, S.; Zagonel, V.; Milwee, S.; more...
    Journal of Gastroenterology and Hepatology (2019)

    Fulltext@MSK | Save
  • V211D mutation in MEK1 causes resistance to MEK inhibitors in colon cancer
    Journal Article

    Gao, Y.; Maria, A.; Na, N.; da Cruz Paula, A.; Gorelick, A. N.; Hechtman, J. F.; Carson, J.; Lefkowitz, R. A.; Weigelt, B.; Taylor, B. S.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Role of hepatic artery infusion chemotherapy in treatment of initially unresectable colorectal liver metastases: A review
    Journal Article

    Datta, J.; Narayan, R. R.; Kemeny, N. E.; D'Angelica, M. I.
    JAMA Surgery (2019)

    Fulltext@MSK | Save